189,99 €
inkl. MwSt.
Sofort per Download lieferbar
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
A huge number of therapeutic studies has been published in rheumatology and clinical immunology. This number grows substantially by the year. As such, it becomes increasingly difficult to keep track of this multitude of studies and the ensuing therapeutic trends. Further to this, a particular study can be referred to in a variety of ways, either as a shortened version of the title or an acronym, adding to the confusion. The book Clinical Trials in Rheumatology provides a summary of the important studies in the field for easy reference. Every study is shown with name, acronym (if in existence),…mehr
- Geräte: PC
- ohne Kopierschutz
- eBook Hilfe
- Größe: 4.39MB
- Upload möglich
Andere Kunden interessierten sich auch für
- Ruediger MuellerClinical Trials in Rheumatology (eBook, PDF)213,99 €
- Cytokines as Potential Therapeutic Targets for Inflammatory Skin Diseases (eBook, PDF)94,95 €
- Musculoskeletal Ultrasonography in Rheumatic Diseases (eBook, PDF)96,29 €
- Perioperative Management of Patients with Rheumatic Disease (eBook, PDF)106,99 €
- Gene Therapy for Autoimmune and Inflammatory Diseases (eBook, PDF)213,99 €
- Joachim SieperClinician's Manual on Ankylosing Spondylitis (eBook, PDF)53,49 €
- Clinical Trials in Rheumatoid Arthritis and Osteoarthritis (eBook, PDF)96,29 €
-
-
-
A huge number of therapeutic studies has been published in rheumatology and clinical immunology. This number grows substantially by the year. As such, it becomes increasingly difficult to keep track of this multitude of studies and the ensuing therapeutic trends. Further to this, a particular study can be referred to in a variety of ways, either as a shortened version of the title or an acronym, adding to the confusion. The book Clinical Trials in Rheumatology provides a summary of the important studies in the field for easy reference. Every study is shown with name, acronym (if in existence), authors, complete citation, study design, results, and summary. An acronym finder is supplied at the beginning of the book. This book is a valuable reference tool for rheumatologists and other clinical specialties, as well as for research scientists interested in immunomodulatory and selected other drug therapies in rheumatologic diseases.
Produktdetails
- Produktdetails
- Verlag: Springer London
- Erscheinungstermin: 1. Dezember 2010
- Englisch
- ISBN-13: 9781849963848
- Artikelnr.: 37358274
- Verlag: Springer London
- Erscheinungstermin: 1. Dezember 2010
- Englisch
- ISBN-13: 9781849963848
- Artikelnr.: 37358274
Rüdiger Müller, MD, is Senior Consultant in rheumatology at the Kantonsspital in St Gallen, Switzerland. Johannes von Kempis, MD, is the Head of the Rheumatology Division at Kanstonsspital in St Gallen, Switzerland.
Rheumatoid Arthritis:- Corticosteroids:- Atorvastatin:- Azathioprine:- Chloroquine/Hydroxychloroquine:- Ciclosporin:- Cyclophosphamide:- Gold:- Leflunomide:- Methotrexate:- Sulfasalazine:- Tacrolimus:- Combination Therapy:- Methotrexate and Hydroxychloroquine:- Methotrexate and Doxycycline:- Methotrexate and Sulfasalazine:- Methotrexate and Civlosporin:- Methotrexate and Hydroxychloroquine and Sulfasalazine:- Methotrexate and Leflunomide:- Methotrexate and Azathioprine:- Methotrexate and Gold:- Gold and Hydroxychloroquine:- Abatacept:- Adalimumab:- Anakinra:- Certolizumab pegol:- Etanercept:- Golimumab:- Infliximab:- Rituximab:- Tocilizumab:- Ankylosing Spondylitis:- Corticosteroids:- Cyclophosphamide:- Leflunomide:- Methotrexate:- Pamindronate:- Sulfasalazine :- Combination therapy:- Adalimumab:- Etanercept:- Golimumab:- Infliximab:- Psoriatic Arthritis;- Chloroquine/Hydroxychloroquine:- Ciclosporin:- Leflunomide:- Methotrexate:- Sulfasalazine:- Adalimumab:- Alefacept:- Etanercept:- Golimumab:- Infliximab:- Ustekinumab:- Systemic Lupus erythematosus:- Corticosteroids:- Azathioprine:- Chloroquine/Hydroxychloroquine:- Cyclophosphamide:- Leflunomide:- Methotrexate:- Mycophenolate mofetil:- Raloxifene:- Tacrolimus:- Combination:- Azathioprine + Ciclosporine:- Hydroxychloroquine and Mycophenolate mofetil:- Infliximab:- Rituximab:- Antiphospholipid Syndrome:- Aspirin vs. Heparin:- Heparin vs. Intravenous Immunoglobulins:- Prednisone + Aspirin:- Warfarin:- Progress. System Sclerosis:- Corticosteroids:- Ambrisentan:- Azathioprine:- Bosentan:- Chlorambucil:- Ciclosporin:- Colchicine:- Cyclophosphamide:- D-Penicillamine:- Methotrexate:- Mycophenolate mofetil:- 5-Fluorouracil:- Etanercept:- Infliximab: Rituximab: Plasma exchange:- Stem cell transplantation:- Raynaud’s phenomenon:- Bosentan:- Diltiazem:- Glyceryl Trinitrate:- Iloprost:- Nifedipine:- Sildenafil:- Dermato/Polymyositis:- Corticosteroids:- Cyclophosphamide:- Immunoglobulins:- Methotrexate:- Mycophenolatemofetil:- Anti-TNF:- Etanercept:- Rituximab:- Sjögren's syndrome:- Hydroxychloroquine:- Leflunomide:- Methotrexate:- Mycophenolate mofetil:- Pilocarpine:- Etanercept:- Infliximab:- Rituximab:- Takayasu arteritis:- Methotrexate:- Mycophenolate mofetil:- Anti-TNF:- Giant cell arteritis:- Corticosteroids:- Ciclosporin:- Methotrexate:- Etanercept:- Infliximab:- Polymyalgia rheumatica:- Corticosteroids:- Azathioprine:- Methotrexate:- Etanercept:- Infliximab:- ANCA-associated Vasculitis incl. trials combined with polyarteritis nodosa:- Azathioprine\:- Co-Trimoxazole:- Cyclophosphamide:- Methotrexate:- Mycophenolate mofetil:- Anti-thymocyte globulin:- Etanercept:- Immunoglobulin:- Infliximab:- Plasma exchange:- Purpura Schoenlein Henoch:- Corticosteroids:- Azathioprine:- Ciclosporine:- Cyclophosphamide:- Morbus Behçet:- Corticosteroids:- Azathioprine:- Ciclosporine:- Colchicine:- Cyclophosphamide:- Dapsone:- Methotrexate:- Mycophenolate mofetil:- Tacrolimus:- Thalidomide:- Etanercept:- Infliximab:- Interferon alfa-2a:- Acronyms:- Abbreviations:-
Rheumatoid Arthritis:- Corticosteroids:- Atorvastatin:- Azathioprine:- Chloroquine/Hydroxychloroquine:- Ciclosporin:- Cyclophosphamide:- Gold:- Leflunomide:- Methotrexate:- Sulfasalazine:- Tacrolimus:- Combination Therapy:- Methotrexate and Hydroxychloroquine:- Methotrexate and Doxycycline:- Methotrexate and Sulfasalazine:- Methotrexate and Civlosporin:- Methotrexate and Hydroxychloroquine and Sulfasalazine:- Methotrexate and Leflunomide:- Methotrexate and Azathioprine:- Methotrexate and Gold:- Gold and Hydroxychloroquine:- Abatacept:- Adalimumab:- Anakinra:- Certolizumab pegol:- Etanercept:- Golimumab:- Infliximab:- Rituximab:- Tocilizumab:- Ankylosing Spondylitis:- Corticosteroids:- Cyclophosphamide:- Leflunomide:- Methotrexate:- Pamindronate:- Sulfasalazine :- Combination therapy:- Adalimumab:- Etanercept:- Golimumab:- Infliximab:- Psoriatic Arthritis;- Chloroquine/Hydroxychloroquine:- Ciclosporin:- Leflunomide:- Methotrexate:- Sulfasalazine:- Adalimumab:- Alefacept:- Etanercept:- Golimumab:- Infliximab:- Ustekinumab:- Systemic Lupus erythematosus:- Corticosteroids:- Azathioprine:- Chloroquine/Hydroxychloroquine:- Cyclophosphamide:- Leflunomide:- Methotrexate:- Mycophenolate mofetil:- Raloxifene:- Tacrolimus:- Combination:- Azathioprine + Ciclosporine:- Hydroxychloroquine and Mycophenolate mofetil:- Infliximab:- Rituximab:- Antiphospholipid Syndrome:- Aspirin vs. Heparin:- Heparin vs. Intravenous Immunoglobulins:- Prednisone + Aspirin:- Warfarin:- Progress. System Sclerosis:- Corticosteroids:- Ambrisentan:- Azathioprine:- Bosentan:- Chlorambucil:- Ciclosporin:- Colchicine:- Cyclophosphamide:- D-Penicillamine:- Methotrexate:- Mycophenolate mofetil:- 5-Fluorouracil:- Etanercept:- Infliximab: Rituximab: Plasma exchange:- Stem cell transplantation:- Raynaud’s phenomenon:- Bosentan:- Diltiazem:- Glyceryl Trinitrate:- Iloprost:- Nifedipine:- Sildenafil:- Dermato/Polymyositis:- Corticosteroids:- Cyclophosphamide:- Immunoglobulins:- Methotrexate:- Mycophenolatemofetil:- Anti-TNF:- Etanercept:- Rituximab:- Sjögren's syndrome:- Hydroxychloroquine:- Leflunomide:- Methotrexate:- Mycophenolate mofetil:- Pilocarpine:- Etanercept:- Infliximab:- Rituximab:- Takayasu arteritis:- Methotrexate:- Mycophenolate mofetil:- Anti-TNF:- Giant cell arteritis:- Corticosteroids:- Ciclosporin:- Methotrexate:- Etanercept:- Infliximab:- Polymyalgia rheumatica:- Corticosteroids:- Azathioprine:- Methotrexate:- Etanercept:- Infliximab:- ANCA-associated Vasculitis incl. trials combined with polyarteritis nodosa:- Azathioprine\:- Co-Trimoxazole:- Cyclophosphamide:- Methotrexate:- Mycophenolate mofetil:- Anti-thymocyte globulin:- Etanercept:- Immunoglobulin:- Infliximab:- Plasma exchange:- Purpura Schoenlein Henoch:- Corticosteroids:- Azathioprine:- Ciclosporine:- Cyclophosphamide:- Morbus Behçet:- Corticosteroids:- Azathioprine:- Ciclosporine:- Colchicine:- Cyclophosphamide:- Dapsone:- Methotrexate:- Mycophenolate mofetil:- Tacrolimus:- Thalidomide:- Etanercept:- Infliximab:- Interferon alfa-2a:- Acronyms:- Abbreviations:-